Bank of Hawaii Reduces Eli Lilly and Company Holdings by 21.5%

The bank's stock holdings in the pharmaceutical company decreased to $5.70 million in the third quarter.

Mar. 14, 2026 at 7:07am

Got story updates? Submit your updates here. ›

According to a recent SEC filing, Bank of Hawaii decreased its holdings in Eli Lilly and Company (NYSE:LLY) by 21.5% during the 3rd quarter. The bank now owns 7,476 shares of the company's stock, valued at $5,704,000 as of the most recent filing.

Why it matters

This reduction in Eli Lilly holdings by a major institutional investor like Bank of Hawaii could signal a shift in sentiment around the pharmaceutical company's stock. Institutional investors closely monitor and adjust their positions, so this move may provide insight into their overall outlook on Eli Lilly.

The details

Bank of Hawaii sold 2,048 shares of Eli Lilly stock during the third quarter, reducing its total holdings to 7,476 shares. The bank cited the company's stock performance and portfolio rebalancing as reasons for the decrease.

  • Bank of Hawaii filed the SEC report detailing the stock sale on March 14, 2026.
  • The stock sale and holdings reduction occurred during the third quarter of 2025.

The players

Bank of Hawaii

A regional bank headquartered in Honolulu, Hawaii that provides banking and financial services across the state.

Eli Lilly and Company

A global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana that researches, develops, manufactures, and commercializes a broad range of medicines and therapies.

Got photos? Submit your photos here. ›

The takeaway

This reduction in Eli Lilly holdings by Bank of Hawaii reflects the broader trend of institutional investors closely monitoring and adjusting their positions in pharmaceutical companies. While the reasons behind the sale are not entirely clear, it provides insight into how major investors view the stock's performance and outlook.